Solasia PharmaSolasia Pharma K.K.4597東証グロース医薬品FY ending Dec 2023, consolidated, IFRS

Solasia Pharma revenue and profit

Revenue changed -43.5% from the prior year.

Five-year trend

Revenue¥617M
FY ending Dec 2017: ¥410M¥410MFY ending Dec 2018: ¥318M¥318MFY ending Dec 2021: ¥559M¥559MFY ending Dec 2022: ¥1.09B¥1.09BFY ending Dec 2023: ¥617M¥617MFY17FY18FY21FY22FY23

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

ROA-41.5%
2017: -15.1%-15.1%2018: -33.7%-33.7%2021: -78.8%-78.8%2022: -81.2%-81.2%2023: -41.5%-41.5%1718212223
PeriodNet marginAsset turnoverROAFinancial leverageROE
2017——×-15.1%—×—
2018——×-33.7%—×—
2021——×-78.8%—×—
2022——×-81.2%—×—
2023——×-41.5%—×—

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Income statement (JPY millions)

ItemFY ending Dec 2017FY ending Dec 2018FY ending Dec 2021FY ending Dec 2022FY ending Dec 2023
Revenue4103185591,092617
Cost of revenue—————
Gross profit—————
SG&A—————
Operating income—————
Pretax income-1,016-2,445-2,442-2,492-1,135
Income tax—————
Net income attributable to owners-1,007-2,422-2,478-2,548-1,112
Operating margin—————

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

ItemFY ending Dec 2017FY ending Dec 2018FY ending Dec 2021FY ending Dec 2022FY ending Dec 2023
Cash and equivalents¥3.37B¥4.05B¥714M¥803M¥728M
Total assets¥6.66B¥7.73B¥3.14B¥3.13B¥2.23B
Net assets—¥7.09B——¥1.88B

Sources

Show source documents (4)
  • EDINET (FSA Japan)

    有価証券報告書-第18期(2025/01/01-2025/12/31)

    ID S100XT682026-03-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第15期(2022/01/01-2022/12/31)

    ID S100QFP52023-03-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第14期(令和3年1月1日-令和3年12月31日)

    ID S100NQ7L2022-03-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第13期(令和2年1月1日-令和2年12月31日)

    ID S100L2ET2021-03-29Open

Extracted from XBRL: 10 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.